Luo Beibei, Xu Wenbo, Luo Feng, Zhang Shuqiong, Li Xiaofei
Department of Laboratory, People's Hospital of Yuxi City, 21 Nieer Road, Yuxi City, Yunnan Province, 653100, P.R. China.
Department of Laboratory, Kunming Third people's hospital, 319 Wujing Road, Kunming City, Yunnan Province, 650041, P.R. China.
BMC Cardiovasc Disord. 2025 Jan 27;25(1):58. doi: 10.1186/s12872-025-04503-3.
Hypertension (HTN) and diabetes frequently coexist. This study aims to elucidate the associations between HTN and glycosylated hemoglobin (HbA1c), as well as the connections between distinct forms of HTN and HbA1c.
We collected data from National Health and Nutrition Examination Survey (NHANES) 2011-2018 in this study, including anthropometric tests and biochemical measures. The HbA1c levels were grouped by participants with diabetes, prediabetes, or no diabetes. Correlations between HbA1c and HTN, isolated systolic hypertension (ISH), and isolated diastolic hypertension (IDH) risk were investigated by logistic analyses. A fitting curve has drown to describe the association between HTN and HbA1c.
Among the 10,503 enrolled participants, The prevalence of HTN notably increased with higher HbA1c levels (P < 0.001). In the adjusted model, compared to the lowest HbA1c group, the odds ratio (OR) with its 95% confidence interval (CI) was 1.22 (1.07 ~ 1.39) for the highest HbA1c group. There was a significant increase in the risk of ISH with higher HbA1c levels in group 3 compared to group 1 (OR: 1.3, 95% CI: 1.1 ~ 1.53).The adjusted model revealed no significant association between HbA1c levels and the risk of IDH.
There is a independent influence of HbA1c on HTN risk in adults in the United States. Notably, the risk of developing HTN increases most rapidly when HbA1c levels approach 5.5%.
高血压(HTN)与糖尿病常并存。本研究旨在阐明高血压与糖化血红蛋白(HbA1c)之间的关联,以及不同类型高血压与HbA1c之间的联系。
本研究收集了2011 - 2018年美国国家健康与营养检查调查(NHANES)的数据,包括人体测量测试和生化指标。根据参与者是否患有糖尿病、糖尿病前期或无糖尿病对HbA1c水平进行分组。通过逻辑分析研究HbA1c与高血压、单纯收缩期高血压(ISH)和单纯舒张期高血压(IDH)风险之间的相关性。绘制拟合曲线以描述高血压与HbA1c之间的关联。
在10503名登记参与者中,高血压患病率随HbA1c水平升高而显著增加(P < 0.001)。在调整模型中,与最低HbA1c组相比,最高HbA1c组的优势比(OR)及其95%置信区间(CI)为1.22(1.07 ~ 1.39)。与第1组相比,第3组中HbA1c水平升高时ISH风险显著增加(OR:1.3,95% CI:1.1 ~ 1.53)。调整模型显示HbA1c水平与IDH风险之间无显著关联。
在美国成年人中,HbA1c对高血压风险有独立影响。值得注意的是,当HbA1c水平接近5.5%时,患高血压的风险增加最为迅速。